.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,409,990

« Back to Dashboard
Patent 6,409,990 protects LYMPHOSEEK KIT and is included in one NDA.

This patent has nine patent family members in seven countries.

Summary for Patent: 6,409,990

Title: Macromolecular carrier for drug and diagnostic agent delivery
Abstract:New macromolecular carriers for drugs and diagnostic agents are described that make use of the chemical attachment of new leashes to oligomeric backbone structures. The synthesis of these leashes and their facile creation, reaction and conjugation with chelators and ligands makes them ideal candidates for use in medicine, and especially diagnostics.
Inventor(s): Vera; David R. (San Diego, CA)
Assignee: The Regents of the University of California (Oakland, CA)
Application Number:09/569,466
Patent Claim Types:
see list of patent claims
Composition; Use; Compound;
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 11th percentile
Forward Citations: 1st percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Navidea Biopharms
LYMPHOSEEK KIT
technetium tc-99m tilmanocept
INJECTABLE;INJECTION202207-001Mar 13, 2013RXYes6,409,990► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,409,990

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria277642► subscribe
Australia5270500► subscribe
Germany60014359► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc